Ferrao P - Search Results

1

Association of paediatric mastocytosis with a polymorphism resulting in an amino acid substitution (M541L) in the transmembrane domain of c-KIT.

Foster R, Byrnes E, Meldrum C, Griffith R, Ross G, Upjohn E, Braue A, Scott R, Varigos G, Ferrao P, Ashman LK. Foster R, et al. Among authors: ferrao p. Br J Dermatol. 2008 Nov;159(5):1160-9. doi: 10.1111/j.1365-2133.2008.08827.x. Epub 2008 Sep 15. Br J Dermatol. 2008. PMID: 18795925

2

Molecular basis of the constitutive activity and STI571 resistance of Asp816Val mutant KIT receptor tyrosine kinase.

Foster R, Griffith R, Ferrao P, Ashman L. Foster R, et al. Among authors: ferrao p. J Mol Graph Model. 2004 Oct;23(2):139-52. doi: 10.1016/j.jmgm.2004.04.003. J Mol Graph Model. 2004. PMID: 15363456

3

Juxtamembrane mutant V560GKit is more sensitive to Imatinib (STI571) compared with wild-type c-kit whereas the kinase domain mutant D816VKit is resistant.

Frost MJ, Ferrao PT, Hughes TP, Ashman LK. Frost MJ, et al. Among authors: ferrao pt. Mol Cancer Ther. 2002 Oct;1(12):1115-24. Mol Cancer Ther. 2002. PMID: 12481435

4

Constitutively active mutant D816VKit induces megakayocyte and mast cell differentiation of early haemopoietic cells from murine foetal liver.

Ferrao PT, Gonda TJ, Ashman LK. Ferrao PT, et al. Leuk Res. 2003 Jun;27(6):547-55. doi: 10.1016/s0145-2126(02)00272-2. Leuk Res. 2003. PMID: 12648515

5

Overexpression of P-glycoprotein in K562 cells does not confer resistance to the growth inhibitory effects of imatinib (STI571) in vitro.

Ferrao PT, Frost MJ, Siah SP, Ashman LK. Ferrao PT, et al. Blood. 2003 Dec 15;102(13):4499-503. doi: 10.1182/blood-2003-01-0083. Epub 2003 Jul 24. Blood. 2003. PMID: 12881321 Free article.

6

Expression of constitutively activated human c-Kit in Myb transformed early myeloid cells leads to factor independence, histiocytic differentiation, and tumorigenicity.

Ferrao P, Gonda TJ, Ashman LK. Ferrao P, et al. Blood. 1997 Dec 1;90(11):4539-52. Blood. 1997. PMID: 9373265 Free article.

7

Effects of mutant c-kit in early myeloid cells.

Ashman LK, Ferrao P, Cole SR, Cambareri AC. Ashman LK, et al. Among authors: ferrao p. Leuk Lymphoma. 2000 Mar;37(1-2):233-43. doi: 10.3109/10428190009057652. Leuk Lymphoma. 2000. PMID: 10721793

8

Effects of mutant c-Kit in early myeloid cells.

Ashman LK, Ferrao P, Cole SR, Cambareri AC. Ashman LK, et al. Among authors: ferrao p. Leuk Lymphoma. 1999 Aug;34(5-6):451-61. doi: 10.3109/10428199909058472. Leuk Lymphoma. 1999. PMID: 10492068 Corrected and republished. Review.

9

Enforced expression of full length c-Myb leads to density-dependent transformation of murine haemopoietic cells.

Ferrao P, Macmillan EM, Ashman LK, Gonda TJ. Ferrao P, et al. Oncogene. 1995 Oct 19;11(8):1631-8. Oncogene. 1995. PMID: 7478588

10

Phosphatidylinositol 3 kinase contributes to the transformation of hematopoietic cells by the D816V c-Kit mutant.

Chian R, Young S, Danilkovitch-Miagkova A, Rönnstrand L, Leonard E, Ferrao P, Ashman L, Linnekin D. Chian R, et al. Among authors: ferrao p. Blood. 2001 Sep 1;98(5):1365-73. doi: 10.1182/blood.v98.5.1365. Blood. 2001. PMID: 11520784 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

84 results

Search Page